摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl (14E)-14-ethylidene-6-hydroxy-2-methyl-19-{[(3,4,5-trihydroxyphenyl)carbonyloxy]methyl}-18-oxa-2,12-diazahexacyclo[9.6.1.1^{9,15}.0^{1,9}.0^{3,8}.0^{12,17}]nonadeca-3(8),4,6-triene-19-carboxylate | 1225196-99-5

中文名称
——
中文别名
——
英文名称
Methyl (14E)-14-ethylidene-6-hydroxy-2-methyl-19-{[(3,4,5-trihydroxyphenyl)carbonyloxy]methyl}-18-oxa-2,12-diazahexacyclo[9.6.1.1^{9,15}.0^{1,9}.0^{3,8}.0^{12,17}]nonadeca-3(8),4,6-triene-19-carboxylate
英文别名
methyl (1R,9S,11S,14E,15S,17S,19R)-14-ethylidene-6-hydroxy-2-methyl-19-[(3,4,5-trihydroxybenzoyl)oxymethyl]-18-oxa-2,12-diazahexacyclo[9.6.1.19,15.01,9.03,8.012,17]nonadeca-3(8),4,6-triene-19-carboxylate
Methyl (14E)-14-ethylidene-6-hydroxy-2-methyl-19-{[(3,4,5-trihydroxyphenyl)carbonyloxy]methyl}-18-oxa-2,12-diazahexacyclo[9.6.1.1^{9,15}.0^{1,9}.0^{3,8}.0^{12,17}]nonadeca-3(8),4,6-triene-19-carboxylate化学式
CAS
1225196-99-5
化学式
C29H30N2O9
mdl
——
分子量
550.565
InChiKey
KQUFXNLUYHXCIV-QTRXUKGZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    40
  • 可旋转键数:
    6
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    149
  • 氢给体数:
    4
  • 氢受体数:
    11

反应信息

  • 作为产物:
    描述:
    alstiphyllanine D三溴化硼 作用下, 以 二氯甲烷 为溶剂, 反应 0.25h, 以30.3%的产率得到Methyl (14E)-14-ethylidene-6-hydroxy-2-methyl-19-{[(3,4,5-trihydroxyphenyl)carbonyloxy]methyl}-18-oxa-2,12-diazahexacyclo[9.6.1.1^{9,15}.0^{1,9}.0^{3,8}.0^{12,17}]nonadeca-3(8),4,6-triene-19-carboxylate
    参考文献:
    名称:
    Alstiphyllanines E–H, picraline and ajmaline-type alkaloids from Alstonia macrophylla inhibiting sodium glucose cotransporter
    摘要:
    Three new picraline-type alkaloids, alstiphyllanines E-G (1-3) and a new ajmaline-type alkaloid, alstiphyllanine H (4) were isolated from the leaves of Alstonia macrophylla together with 16 related alkaloids (5-20). Structures and stereochemistry of 1-4 were fully elucidated and characterized by 2D NMR analysis. Alstiphyllanines E and F (1 and 2) showed moderate Na+-glucose cotransporter (SGLT1 and SGLT2) inhibitory activity. A series of a hydroxy substituted derivatives 21-28 at C-17 of the picraline-type alkaloids have been derived as having potent SGLT inhibitory activity. 10-Methoxy-N(1)-methylburnamine-17-O-veratrate (6) exhibited potent inhibitory activity, suggesting that the presence of an ester side chain at C-17 may be important to show SGLT inhibitory activity. Structure activity relationship of alstiphyllanines on inhibitory activity of SGLT was discussed. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.01.077
点击查看最新优质反应信息